The Swiss Group for Clinical Research is seeking individuals suffering from mesothelioma cancer to participate in a new clinical trial. The trial, led by Dr. Florian Strasser of Kantonsspital Hospital in St. Gallen Switzerland, will test the Electronic Monitoring of symptoms and Syndromes Associated with Advanced Cancer (E-MOSAIC), a handheld device designed to improve doctor/patient communication.
The team of researchers will test the efficiency of the E-MOSAIC when it comes to planning cancer patient treatment.
Patient Requirements
The clinical trial will be controlled, randomized and longitudinal. It will span a six-week period and will utilize approximately 24 doctors. Researchers are seeking 192 patients with malignant mesothelioma to participate in the study. All patients must be at least 18 years old and must be in the advanced stages of mesothelioma cancer.
All participating cancer patients must also be undergoing weekly or biweekly palliative cancer treatment when they enroll to qualify for the study.
If you have malignant mesothelioma cancer and would like to participate in the study, contact Dr. Stasser at florian.strasser@kssg.ch or 41-71-494-1111.
Have you or someone you know been diagnosed with mesothelioma cancer? If so, contact us today to seek speak to an experienced mesothelioma attorney. You may qualify for compensation for all medical bills and any pain and suffering caused by your illness.
